Hims & Hers Health Inc. has acquired a California-based manufacturing facility to expand its range of peptide treatments, ...

After having massive success with off-brand weight-loss drugs, the millennial-focused telehealth company Hims & Hers (HIMS) ...

Investors could be overestimating the contribution of Hims & Hers' compounded GLP-1 medications to its top line. Read why I ...

Hims & Hers' acquisition of Trybe Labs broadens its treatment range and enhances its competitive edge through increased data ...

Shares tumbled 21% to $52.22. Over the last year, the stock has surged more than 450%.

The telehealth company has been selling a copycat version of a popular obesity drug during the recent shortage.

It may be early, but some blazing investments have already delivered wealth-altering gains in this young year.

Hims & Hers Health Inc. has been on a meteoric rise, with shares soaring over 145% this year and more than sixfold in the ...

Telehealth pioneer Hims & Hers Health (HIMS) stock is soaring, with a 12% gain in recent days and a whopping 176% in the last ...

Whether you’re trying to grow out your hair or think you may be noticing the early signs of balding, you may be wondering ...

Nutrafol’s latest product ushers the brand into new (hair care) territory. And it’s a terrific option for guys with short ...